DrugPatentWatch Database Preview
Profile for Estonia Patent: 200200304
US Patent Family Members and Approved Drugs for Estonia Patent: 200200304
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Sign Up | Dec 8, 2020 | Pfizer Inc | XELJANZ XR | tofacitinib citrate |
➤ Sign Up | Dec 8, 2020 | Pf Prism Cv | XELJANZ | tofacitinib citrate |
➤ Sign Up | Dec 8, 2020 | Pfizer Inc | XELJANZ XR | tofacitinib citrate |
➤ Sign Up | Dec 8, 2020 | Pf Prism Cv | XELJANZ | tofacitinib citrate |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |